MedPath

Use of Shockwave therapy versus placebo in the treatment of tight calf muscles in children with cerebral palsy

Phase 3
Not yet recruiting
Conditions
Spastic quadriplegic cerebral palsy, (2) ICD-10 Condition: G801||Spastic diplegic cerebral palsy, (3) ICD-10 Condition: G802||Spastic hemiplegic cerebral palsy,
Registration Number
CTRI/2019/06/019666
Lead Sponsor
Christian Medical College Vellore
Brief Summary

Cerebral palsy (CP) isone of the leading causes of movement and posture disorders. Cerebral palsy ischaracterised by spasticity, decreased selective motor control and progressivejoint contractures. Calf spasticity is one of the common clinical featureswhich results in ankle equinus and decreased range of ankle dorsiflexion, whichif untreated, subsequently results in equinus contracture. rESWT is a newmodality of treatment for spasticity, In this study we will be comparing theefficacy of rESWT in improving the ROM at the ankle as well as decreasing calfspasticity.

 Children withCP under the age of 7 will be screened in the Paediatric Orthopaedicout-patient department (OPD) and will be randomised to an intervention groupand a control group, 45 in each group. The intervention group will receiverESWT and the control group will receive sham rESWT. Both groups will receive astandardised regime of Oral baclofen and physiotherapy. rEWST will be given in2 sittings , 3 days apart.  The childrenwill be followed up at 6 weeks and 3 months.

 The primaryoutcome measure which is improvement in ankle dorsiflexion range will bemeasured by using standardised clinical photographs and improvement inspasticity by Modified Ashworth Score. At final followup, patient / parentsatisfaction will be evaluated on a 5 point likert scale

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

Children with CP under 7 years of age with calf spasticity, MAS of 2 or more.

Exclusion Criteria

Previous surgery to calf Botox injection to the calf Inability to comply with followup Bleeding disorders/blood dyscrasias/ seizure disorder.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Calibrated passive range of motion of the ankleImmediate procedure | 6 weeks | 3 months
Secondary Outcome Measures
NameTimeMethod
Modified Ashworth Scale (MAS)Parent reported satisfaction on likert scale

Trial Locations

Locations (1)

Paediatric Orthopaedic Out patient Department

🇮🇳

Vellore, TAMIL NADU, India

Paediatric Orthopaedic Out patient Department
🇮🇳Vellore, TAMIL NADU, India
Dr Raj Manohar Nishanth Gollamandala
Principal investigator
9720002327
nishanthgrm@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.